Abstract:Abstract Alzheimer’s disease (AD) is the most common neurodegenerative disorder leading to dementia in the elderly population. AD is associated with the buildup of β-amyloid and tau, which aggregate into extracellular plaques and neurofibrillary tangles. Although the exact mechanism of pathological process of AD is unclear, the dysfunction of protein degradation mechanisms has been proposed to play an important role in AD. The cellular degradation of abnormal or misfolded proteins consists of three different mechanisms: the ubiquitin proteasomal system (UPS), autophagy-lysosomal pathway (ALP), and interaction of molecular chaperones with UPS or ALP. Any disturbance to these systems causes proteins to accumulate, resulting in pathological process of AD. In this review, we summarize the knowledge of protein degradation pathways in the pathogenesis of AD in light of the current literature. In the future, the regulation UPS or ALP machineries could be the cornerstones of the treatment of AD.

What problem does this paper attempt to address?

This paper attempts to explore the roles of the Ubiquitin - Proteasomal System (UPS) and the Autophagy - Lysosome Pathway (ALP) in Alzheimer's Disease (AD). AD is a common neurodegenerative disease that mainly affects the elderly population, and is characterized by the accumulation of β - amyloid (Aβ) and tau proteins in the brain, forming extracellular plaques and neurofibrillary tangles. Although the exact pathogenesis of AD remains unclear, the dysfunction of protein degradation mechanisms is considered to play an important role in the pathological process of AD. The paper summarizes the current knowledge in the literature regarding protein degradation pathways in the pathogenesis of AD and points out that regulating UPS or ALP mechanisms may be the key to future AD treatment. Specifically, the paper explores the following aspects: 1. **Dysfunction of UPS in AD**: - UPS - mediated protein degradation is the main degradation pathway for normal and abnormal proteins, such as hyperphosphorylated tau protein and aggregated Aβ protein. - The UPS dysfunction in neurons of AD patients leads to the accumulation of ubiquitinated proteins and changes in the composition of proteasome subunits, thereby reducing proteasome activity and α - secretase activity, and ultimately leading to the production of Aβ. - The paper also discusses the expression changes of key enzymes such as E2 - 25K, Parkin, UCHL1, CHIP and HRD1 in AD and their effects on Aβ metabolism and UPS. 2. **Role of the Autophagy - Lysosome Pathway in AD**: - The Autophagy - Lysosome Pathway is an important pathway for removing abnormal protein aggregates and maintaining protein homeostasis. - In the early stage of AD, the dysfunction of the Autophagy - Lysosome Pathway has emerged, manifested as a large accumulation of autophagosomes and impaired lysosomal function. - The paper describes in detail the key steps in the autophagy process, including the formation of autophagosomes, their fusion with lysosomes, and protein degradation. 3. **Interaction between Molecular Chaperones and UPS and ALP**: - Molecular chaperones play an important role in protein folding and preventing the aggregation of toxic proteins. - The paper discusses the roles of molecular chaperones such as Hsp70 and Hsp90 in AD and how they promote the degradation of Aβ and tau proteins. In summary, this paper aims to provide potential targets and strategies for future AD treatment by reviewing the roles of UPS and ALP in AD.

The role of ubiquitin proteasomal system and autophagy-lysosome pathway in Alzheimer’s disease

Progress in molecular mechanisms of β-amyloid peptides in alzheimer's disease

Molecular Mechanism of Autophagy: Its Role in the Therapy of Alzheimer’s Disease

Impairment of the autophagy–lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potential

Autophagy in Alzheimer's Disease Pathogenesis: Therapeutic Potential and Future Perspectives.

Autophagy in Alzheimer’s disease pathogenesis: Therapeutic potential and future perspectives

Involvement of ubiquitination in Alzheimer's disease

Roles and Mechanisms of the Protein Quality Control System in Alzheimer's Disease

Molecular Mechanisms of ER Stress and UPR in the Pathogenesis of Alzheimer’s Disease

The emerging roles of protein homeostasis-governing pathways in Alzheimer's disease

Autophagy-lysosomal pathway impairment and cathepsin dysregulation in Alzheimer's disease

The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer’s Disease

Defective Autophagy and Mitophagy in Alzheimer's Disease: Mechanisms and Translational Implications

Autophagy Modulation for Alzheimer's Disease Therapy.

The Role of Autophagy in Alzheimer's Disease and Its Potential for Therapy

DUBs in Alzheimer's Disease: Mechanisms and Therapeutic Implications.

Roles of O-GlcNAcylation on amyloid-β precursor protein processing, tau phosphorylation, and hippocampal synapses dysfunction in Alzheimer’s disease

The emerging role of autophagy and mitophagy in tauopathies: From pathogenesis to translational implications in Alzheimer's disease

Disrupted ubiquitin proteasome system underlying tau accumulation in Alzheimer’s disease

Targeting Autophagy for the Treatment of Alzheimer’s Disease: Challenges and Opportunities

Dysregulation of Ubiquitin-Proteasome System in Neurodegenerative Diseases